Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics - Wikidata - wikimedia - TriplyDB

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

http://www.wikidata.org/entity/Q34267466

about

Salinomycin as a drug for targeting human cancer stem cells Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy Model of tumor dormancy/recurrence after short-term chemotherapy A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells.Transglutaminase regulation of cell function.Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.ABC transporters in CSCs membranes as a novel target for treating tumor relapse.Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment.Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.New Insights on Glucosylceramide Synthase in Cancer Drug Resistance and Myelosuppression.Contribution of TIP30 to chemoresistance in laryngeal carcinoma.Illuminating the lateral organization of cell-surface CD24 and CD44 through plasmon coupling between Au nanoparticle immunolabels.A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells.Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations.Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters.Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus.Effects of Withania somnifera and Tinospora cordifolia extracts on the side population phenotype of human epithelial cancer cells: toward targeting multidrug resistance in cancer.Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics.Choosing the right cell line for breast cancer research Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse.High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer.Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance.Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis.The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin.JNK is required for maintaining the tumor-initiating cell-like properties of acquired chemoresistant human cancer cells.Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells.Screening specific polypeptides of breast cancer stem cells from a phage display random peptide library.The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase

P2860

Q21285139-C5B21D8C-E99F-475C-9E37-154A5CF5D035 Q26824316-5B740D9A-D79C-4AFF-962A-08DAF5BDE04A Q27004672-39F85A24-F38C-4AB9-AC16-53FDA1794F0B Q28539003-2E9B6795-5C27-473B-96ED-E3C9E250A874 Q28543175-98694463-49FA-49B8-A504-CBBD64EB2FFE Q30353532-E2A3858A-41C1-461A-B05B-08A034352020 Q33665716-902DA9A5-E5E6-406E-BC73-21AC683C02F5 Q33685020-44063B58-DA95-4230-9DA6-5BF63EBE3839 Q33707936-B91F31B7-14BE-4AB3-90BB-8E2CDC2F510A Q33733991-94F888E1-995C-4320-A8CF-919C2CB4222D Q33815839-435827B3-1C28-44BC-B05B-5328BDB8029E Q33879326-FE2404EB-6F70-4E44-8E71-C46C8170F714 Q34007740-17219DD5-E5A7-4AD0-94A9-2A9501A30977 Q34143362-290E6F5F-6820-4AF0-B48A-F61531AD6311 Q34499844-D68F9EC5-BF16-4E21-9987-26015FC8EC7A Q34541595-58A14896-BB71-4179-92D1-A2A51C9EC463 Q34548478-0C379191-1EF7-4290-9E1E-0F27576F7C97 Q34799952-71B086DC-3451-45A6-8E01-4F520D2A4534 Q35063763-405BF27E-603D-4239-BE5A-EDDE43B37B34 Q35075767-BD89BFEE-6A2E-476B-BD6B-93D7C6AC3304 Q35128711-CBCF76DD-F4A8-431C-B79F-A3AFE58EBEC5 Q35285768-851B7E4F-6096-4248-AB90-92BFBCEE177A Q35535977-73769B83-DB4A-42F6-9D51-0361CA1346CD Q35558646-8CC6E3C6-0587-41DD-83A3-5591CFB61F04 Q35575176-6583BE9C-D8B6-4AED-A35D-0314370971A8 Q35585820-0FEA9218-7BE8-4BA0-AFAE-FB878E5F652B Q35608671-CE303E3F-4F47-4F25-9BA6-CA8FE1293F1C Q35686250-244B922A-143C-4CE9-A3B3-0A870021CCA5 Q35759165-66CD1ADF-DAA9-4C89-AFFF-C659BEAAAC88 Q35859038-CD80C6D3-1731-43A5-864E-8894F9D896BB Q35889609-C39CE0FC-D52A-4A36-8F05-84FFF99C0712 Q35921899-309C4066-8530-4CFE-A17B-34AEAD082D40 Q36008522-C7BCE0A6-FADE-4FA0-B82D-FF6E9A51420C Q36034269-5DDD3A5B-CA8E-4045-B313-02C848BCFEF6 Q36037099-55D0D7A5-3144-434E-84A2-BC3A81800B33 Q36057092-5E621761-3750-4472-8766-1CF25F2AE5C9 Q36210924-D38E4CCE-1EC8-4235-9D23-7A2EE9E99C32 Q36216250-C3ECDCD0-5772-4E3F-9C8E-91B43D8584BB Q36254809-E778CCBB-0764-47A1-88FE-E251669E0B2A Q36269159-F37B69B7-C9B3-443E-B14C-CE04176A80B1

P2860

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics

http://www.wikidata.org/entity/Q34267466

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Prolonged drug selection of br ...... ncer stem cell characteristics

@ast

Prolonged drug selection of br ...... ncer stem cell characteristics

@en

Prolonged drug selection of br ...... ncer stem cell characteristics

@nl

type

label

Prolonged drug selection of br ...... ncer stem cell characteristics

@ast

Prolonged drug selection of br ...... ncer stem cell characteristics

@en

Prolonged drug selection of br ...... ncer stem cell characteristics

@nl

prefLabel

Prolonged drug selection of br ...... ncer stem cell characteristics

@ast

Prolonged drug selection of br ...... ncer stem cell characteristics

@en

Prolonged drug selection of br ...... ncer stem cell characteristics

@nl

P1433

Q34267466-1AA0E785-0E16-4BE5-8F24-D900E6AF1245

P1476

Q34267466-BCA412B3-864A-47EF-B63E-1E7BB4ED1951

P2093

Q34267466-328F4E05-4BB1-4E85-AE7E-9D0128986C64

Q34267466-536C24DC-A647-4732-A91D-FCDE59F8CEC0

Q34267466-5D54BC26-6CAF-4175-A57F-F1B90334191F

Q34267466-8657E15D-E22F-49D8-8402-3BD668B55C0F

Q34267466-A58D0FFA-B503-4900-8B6D-C51E7CFD093A

Q34267466-AB24DADE-3CF2-4932-BFA9-E9E3816E30ED

Q34267466-E564CDA3-EA90-4E18-95C1-DADB666634EB

Q34267466-EEA6F7DF-DC70-4F7B-B43A-9DA7FC7FBF03

P2860

Q34267466-006EF5E9-9741-4002-BCA1-78D53B77D6F5

Q34267466-0184020E-4677-4BD0-9934-B87260697F10

Q34267466-04085154-C2C8-47AB-9D5F-A1872EF7C6C9

Q34267466-0E865859-92D5-46E1-B9D5-600FBDCD2364

Q34267466-1B44187E-014B-49CB-8C80-ABE23F4C7329

Q34267466-20362F09-FC6E-4748-ABDC-AAAFD94D1980

Q34267466-206D090E-77A6-465F-A032-9769BE95C00B

Q34267466-23DF55E2-236C-40FD-8632-61D841F911D9

Q34267466-27C61D7F-1EF3-433A-8A38-27A790100BD3

Q34267466-2A89A11E-8064-4D89-8381-F8B4F89C6651

P304

Q34267466-951E5F58-EA60-4533-8440-328A93A88405

P31

Q34267466-44C1A4F3-9A9A-439F-B6A7-92012D181EDC

P356

Q34267466-83FE69EC-F079-4594-9497-0672CEE2C7BB

P407

Q34267466-BEAADCF1-68D2-4A1D-898E-5D9A600EBBDA

P433

Q34267466-B1EA5A13-F582-4D90-8961-70D24C7EE607

P478

Q34267466-5D06C200-1730-46A5-AF71-F5AD0BC2E4BD

P50

Q34267466-FDF5BBCC-6C83-4E5F-923F-24B0BBF18CFA

P577

Q34267466-C329AC9C-ACB5-47AA-B7AA-39AAB859D0CB

P5875

Q34267466-96A113CA-48DC-491F-A810-D76B079F8E38

P698

Q34267466-DE05E730-1B4A-4561-8622-162B7A87909B

P932

Q34267466-DAEE9828-006D-44C7-8740-55CF9D89EA98

P356

P1433

Journal of the National Cancer Institute

P1476

Prolonged drug selection of br ...... ncer stem cell characteristics

@en

P2093

Chung-Pu Wu

http://www.w3.org/2001/XMLSchema#string

Crystal D Salcido

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Gillet

http://www.w3.org/2001/XMLSchema#string

Jennifer M Fostel

http://www.w3.org/2001/XMLSchema#string

Lyuba Varticovski

http://www.w3.org/2001/XMLSchema#string

Melanie D Mumau

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

Suresh V Ambudkar

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators

Multidrug resistance in cancer: role of ATP-dependent transporters

P304

1637-1652

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJQ361

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Anna M. Calcagno

P577

2010-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47384445

http://www.w3.org/2001/XMLSchema#string

P698

20935265

http://www.w3.org/2001/XMLSchema#string

P932

2970576

http://www.w3.org/2001/XMLSchema#string